Awareness and Acceptability of Parents towards the Typhoid Conjugate Vaccine: A Cross-Sectional Study from a Tertiary Hospital in Lahore, Pakistan
A cross-sectional study of 290 parents at a tertiary hospital in Lahore reveals that while awareness and acceptability of the Typhoid Conjugate Vaccine are generally high, actual vaccination rates remain suboptimal due to barriers such as lower education levels, rural residence, and specific misconceptions, highlighting the need for targeted interventions to improve timely immunization.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Typhoid fever is a serious illness that spreads when people consume food or water contaminated with waste. It is caused by a specific type of bacteria that thrives in areas where sanitation is poor and sewage systems are inadequate. For decades, the primary way to fight this disease has been through antibiotics, but a dangerous new version of the bacteria has emerged that resists many common medicines, making the infection much harder to treat. Because curing the disease has become so difficult, scientists and health officials have turned their focus to prevention. A newer type of vaccine, designed to teach the body to fight the bacteria before it ever enters, offers a powerful shield. However, for any vaccine to work, people must know it exists and be willing to use it. In many parts of the world, fear, misinformation, and a lack of trust can stop families from protecting their children, leaving them vulnerable to a preventable sickness.
In a large teaching hospital in Lahore, Pakistan, a team of researchers set out to understand how parents felt about this new typhoid vaccine. They wanted to know if families were aware of the vaccine's existence, whether they trusted it enough to give it to their children, and what factors might be stopping them from doing so. The team interviewed 290 parents who were visiting the hospital with their children. These parents represented a mix of backgrounds, with most living in the city and a significant portion having little to no formal schooling. The researchers asked them direct questions about what they knew regarding the new shot, whether they had already received it, and what their thoughts were on its safety and necessity. They also used a standard set of questions designed to measure how hesitant a parent might be about vaccines in general, adapting them specifically for this new typhoid shot.
The results painted a picture of a population that is largely open to the vaccine but faces significant hurdles in actually getting it. About 70 percent of the parents knew that the government had introduced a new typhoid vaccine. Among those who were aware, more than half had already vaccinated their children. However, the study found that even among parents who had not yet vaccinated their children, a strong majority, roughly 71 percent, said they were willing to do so if given the chance. This suggests that the main barrier is not a deep-seated refusal to vaccinate, but rather a gap in access or information. Only a small fraction of the parents, about 17 percent, showed signs of being hesitant or unwilling to vaccinate.
When the researchers looked closer at who was getting vaccinated, clear patterns emerged. Children were more likely to have received the shot if their mothers had completed high school, if the family lived in an urban area, and if the parents had received information directly from a doctor. Interestingly, the study found that fathers were more likely to be aware of the vaccine than mothers, and they were also more accepting of it. This contrasts with some other research that suggests mothers are usually the primary decision-makers for child health, hinting that in this specific setting, fathers may play a larger role in vaccine awareness. The source of information mattered greatly as well. Parents who learned about the vaccine from doctors were far more likely to know the correct number of doses needed and were less likely to be hesitant. In contrast, those who relied on mass media or friends and family were more likely to be unsure or to hold incorrect beliefs about the vaccine.
A significant portion of the hesitation that did exist was rooted in specific fears and misconceptions. Some parents worried that the vaccine contained ingredients forbidden by their religion, while others suspected it was part of a political plot or a form of population control. The study found that parents who held these beliefs were significantly more likely to refuse the vaccine. Another common concern was the fear of side effects, with many parents worried the shot could make their child sick. The researchers noted that while the vaccine is known to cause only mild reactions like a low fever or soreness at the injection site, the fear of serious harm was a powerful deterrent. The study also highlighted a confusion between this typhoid vaccine and the vaccines for the coronavirus pandemic, which were introduced around the same time. This overlap in timing seemed to muddy the waters for many families, making it difficult for them to distinguish between the two different medical campaigns.
Despite the high level of willingness to vaccinate, the actual rate of children receiving the shot was lower than expected. The researchers concluded that while the attitude of the parents is generally positive, the system is not yet delivering the vaccine effectively to all who want it. The gap between knowing about the vaccine and actually getting it suggests that simply introducing the shot is not enough. The findings point to a need for better communication, particularly from doctors and healthcare workers, to clear up confusion about dosage and safety. It also suggests that addressing the specific religious and political rumors circulating in the community is essential to reaching the families who remain on the sidelines. The study serves as a reminder that even when a powerful tool exists to stop a deadly disease, its success depends entirely on the trust and understanding of the people it is meant to protect.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.